Published in BMJ on January 24, 2013
Pricing human papillomavirus vaccines: lessons from Italy. Pharmacoeconomics (2012) 1.78
Economic evaluation of human papilloma virus vaccination in the European Union: a critical review. Intern Emerg Med (2011) 1.72
The burden of moderate to severe psoriasis: an overview. Pharmacoeconomics (2012) 1.18
Pharmaceutical policy in Italy: towards a structural change? Health Policy (2005) 1.15
Comment on: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers". Appl Health Econ Health Policy (2014) 1.06
Should we really worry about "launch delays" of new drugs in OECD countries? Eur J Health Econ (2007) 0.96
A critical systematic review of budget impact analyses on drugs in the EU countries. Appl Health Econ Health Policy (2014) 0.92
Health status, resource consumption, and costs of dysthymia. A multi-center two-year longitudinal study. J Affect Disord (2005) 0.90
Pain in primary care: an Italian survey. Eur J Public Health (2005) 0.89
Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness? Eur J Health Econ (2015) 0.86
A review of the costs of managing childhood epilepsy. Pharmacoeconomics (2005) 0.85
Drug sales in four European countries still differ. BMJ (2003) 0.85
Italian risk-sharing agreements on drugs: are they worthwhile? Eur J Health Econ (2015) 0.84
Regional HTA in Italy: promising or confusing? Health Policy (2012) 0.84
Western European markets for biosimilar and generic drugs: worth differentiating. Eur J Health Econ (2015) 0.84
Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies. Pharmacoeconomics (2014) 0.84
Biosimilar versus generic drugs: same but different? Appl Health Econ Health Policy (2015) 0.83
The Bayesian model on human papillomavirus vaccination in Italy lacks transparency. Med Care (2013) 0.83
Budget impact analysis in economic evaluation: a proposal for a clearer definition. Eur J Health Econ (2011) 0.82
Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS). Epilepsia (2004) 0.82
Economic analysis of newer antiepileptic drugs. CNS Drugs (2008) 0.81
Health technology assessment: for whom the bell tolls? Eur J Health Econ (2008) 0.81
HPV vaccination for boys? Talking economic sense. J Sex Med (2012) 0.80
Healthcare costs of COPD in Italian referral centres: a prospective study. Respir Med (2007) 0.79
Could co-payments on drugs help to make EU health care systems less open to political influence? Eur J Health Econ (2013) 0.77
Utilization and costs of antiepileptic drugs in the elderly: still an unsolved issue. Drugs Aging (2009) 0.76
Cost minimisation analysis of 12 or 24 weeks of peginterferon alfa-2b + ribavirin for hepatitis C virus. J Med Econ (2008) 0.76
Utilities and QALYs in health economic evaluations: glossary and introduction. Intern Emerg Med (2010) 0.75
Re: The health technology assessment of bivalent HPV vaccine Cervarix® in Italy. Vaccine (2011) 0.75
HPV vaccine prices in Italy. BMJ (2011) 0.75
The stoma appliances market in five European countries: a comparative analysis. Appl Health Econ Health Policy (2002) 0.75
Health status, resource consumption, and costs of dysthymic patients in Italian primary care. Epidemiol Psichiatr Soc (2004) 0.75
Medical costs of glaucoma and ocular hypertension in Italian referral centres: a prospective study. Ophthalmologica (2007) 0.75
A critical review of the full economic evaluations of pharmacological treatments for glaucoma. J Med Econ (2008) 0.75
Direct medical costs of monitoring and treating patients with Takayasu arteritis in Italy. Eur J Health Econ (2004) 0.75
[Pharmacoeconomic evaluations on antipsychotics in schizophrenia: a review of the Italian studies]. Epidemiol Psichiatr Soc (2006) 0.75
Long-term modeling on HPV vaccination: do we really need any more? Expert Rev Pharmacoecon Outcomes Res (2015) 0.75
Direct medical costs of mycosis fungoides in specialized Italian hospital departments. Haematologica (2005) 0.75
Vaccination planning and vaccine prices in a decentralizing country - Italy. Expert Rev Pharmacoecon Outcomes Res (2014) 0.75
Pharmaceutical policy in Italy: Theory, politics and practice. Eur J Health Econ (2006) 0.75
To model or not to model: lessons from two vaccinations. Eur J Health Econ (2011) 0.75